---
title: "Amgen Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296267639.md"
description: "Amgen Inc. (AMGN) shares rose 1.41% to $425.28 on Tuesday, marking a second consecutive day of gains and hitting a new 52-week high. Despite these daily gains, Amgen underperformed relative to competitors like Johnson & Johnson, Pfizer, and AbbVie during a broader market decline where the S&P 500 and Dow Jones fell. Trading volume remained below its 50-day average."
datetime: "2026-08-18T20:34:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296267639.md)
  - [en](https://longbridge.com/en/news/296267639.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296267639.md)
generator: "portal-rs"
---

# Amgen Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Amgen Inc. (AMGN) advanced 1.41% to $425.28 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.69% to 7,691.76 and Dow Jones Industrial Average falling 0.22% to 53,343.40.

This was the stock's second consecutive day of gains.

Amgen Inc. hit a new 52-week high, surpassing its previous peak of $421.79, which the company achieved on August 11th.

The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 3.33% to $271.11, Pfizer Inc. (PFE) rose 1.41% to $27.25, and AbbVie Inc. (ABBV) rose 3.43% to $258.92.

Trading volume (2.6 M) remained 235,052 below its 50-day average volume of 2.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-18-26 1634ET

### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)

## Related News & Research

- [UK regulator suspends Amgen's Tavneos for new patients over unreliable data](https://longbridge.com/en/news/297642592.md)
- [Strait & Sound Wealth Management LLC Invests $1.92 Million in Amgen Inc. $AMGN](https://longbridge.com/en/news/297400046.md)
- [Morgan Stanley raises Teleperformance stake to 5.17% of capital, 5.04% of voting rights](https://longbridge.com/en/news/297668225.md)
- [Teleperformance reports 59,874,365 shares outstanding as of Aug. 31, 2026](https://longbridge.com/en/news/297677546.md)
- [Helen of Troy director Marlo Michelle Cormier Platz files initial beneficial ownership statement](https://longbridge.com/en/news/297833532.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**